UK Exports to US Plunge 25 Following Trump Tariffs Resulting in Trade Deficit TechD Cybersecuritys Total Income Surges 76 to 5325 Crore in FY26 Salesforce CEO Marc Benioff Outlines Turnaround Plan Amid Stock Slump Focus on Products and Buybacks Mortgage Rates Decline Across the Board on May 27 2026 Extending Recent Downward Trend Broadening Inflation Pressures Beyond Iran and Oil Consumers Face Reacceleration in Multiple Categories Microsoft Appoints Accessibility Veteran to Lead Responsible AI Development Amid Speed vs Safety Tensions Addentax Group Corp Q1 2025 Earnings Net Loss Narrowing as Stock Gains 26 GLUE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Phillips 66 Q1 2026 Earnings Surprising Profit Amid a Challenging Macro Environment BK Q1 2026 Earnings EPS Surpasses Estimates by 1326 White Mountains Insurance Group WTM Q2 2025 Earnings EPS Misses Estimates Stock Declines Magnolia Oil Gas Corporation MGY Q1 2026 Earnings Modest EPS Beat Amid Stable Operations NMP Acquisition Corp NMP Holds Steady Near Support as SPAC Trading Remains Tepid Adamas Trust Notes ADAMI Edge Lower Amid Cautious Fixed Income Sentiment ICON plc Surges 1545 Strong Momentum Tests Resistance Voya Emerging Markets High Income Dividend Equity Fund IHD Edges Higher as Income Seekers Take Notice Lionheart Holdings Warrant CUBWW Holds Steady at 017 Amid Narrow Trading Range Bank of America Adjusts Apple Price Target Amid Artificial Intelligence Developments Qualcomm Shares Surge as Investors Eye AI Device Boom MENA Leaders Advocate for Holistic Housing Policy Beyond Bricks and Mortar at Baku Forum US Job Market Tightens for International Graduates Immigration Hurdles and Hiring Slowdown Reshape Talent Landscape Oil Supply Crunch Expected Later Than Initially Anticipated Nvidia Shares Dip 13 Despite 745 Billion Profit and 102 Billion Buyback Amazon UK Chief Urges Shift in Blaming Youth for Unemployment Points to Education System Gaps TD SYNNEX SNX Q1 2026 Earnings Massive EPS Beat Drives Optimism Revenue Not Disclosed Vor Biopharma Surges 546 as Buyers Defend Key Support Level VOR